tau protein, ischemic injury and vascular dementia

被引:2
作者
Mukaetova-Ladinska, Elizabeta B. [1 ]
Li, Mosi [2 ]
Kalaria, Raj N. [1 ]
机构
[1] Newcastle Univ, Inst Neurosci, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England
[2] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH16 4SB, Midlothian, Scotland
关键词
Alzheimer's disease; cerebrospinal fluid biomarkers; cerebral ischemia; tau protein; vascular dementia;
D O I
10.2217/fnl.15.46
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Clinical, neuroimaging and neuropathological studies have confirmed overlap between Alzheimer's disease (AD) and vascular dementia (VaD). Classical neuropathological changes of AD (plaques and tangles) can be present in VaD.We review neuroimaging, biochemical and animal studies to consider the role of tau protein in ischemic injury and VaD pathogenesis. The evidence comes largely from transgenic animal studies that confirm that tau transgenes influence cerebral vasculature. Clinicobiochemical studies in the cerebrospinal fluid (CSF) have, similarly, confirmed alterations in both total and phosphorylated tau protein in VaD. These data suggest that tau protein not only serves as a potential diagnostic tool for differential diagnosis of VaD from other types of dementia, but may also be a therapeutic target in ischemic stroke.
引用
收藏
页码:559 / 575
页数:17
相关论文
共 125 条
[1]
Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors [J].
Allan, Louise M. ;
Rowan, Elise N. ;
Firbank, Michael J. ;
Thomas, Alan J. ;
Parry, Stephen W. ;
Polvikoski, Tuomo M. ;
O'Brien, John T. ;
Kalaria, Raj N. .
BRAIN, 2011, 134 :3713-3724
[2]
Cerebrospinal Fluid Levels of a 20-22 kDa NH2 Fragment of Human Tau Provide a Novel Neuronal Injury Biomarker in Alzheimer's Disease and Other Dementias [J].
Amadoro, Giuseppina ;
Corsetti, Veronica ;
Sancesario, Giulia Maria ;
Lubrano, Adele ;
Melchiorri, Gaia ;
Bernardini, Sergio ;
Calissano, Pietro ;
Sancesario, Giuseppe .
JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (01) :211-226
[3]
STRUCTURE AND NOVEL EXONS OF THE HUMAN-TAU GENE [J].
ANDREADIS, A ;
BROWN, WM ;
KOSIK, KS .
BIOCHEMISTRY, 1992, 31 (43) :10626-10633
[4]
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease:: a community based follow up study [J].
Andreasen, N ;
Vanmechelen, E ;
Van de Voorde, A ;
Davidsson, P ;
Hesse, C ;
Tarvonen, S ;
Räihä, I ;
Sourander, L ;
Winblad, B ;
Blennow, K .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03) :298-305
[5]
CSF markers for Alzheimer's disease:: Total Tau, phospho-tau and Aβ42 [J].
Andreasen, N ;
Sjögren, M ;
Blennow, K .
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2003, 4 (04) :147-155
[6]
No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia [J].
Arai, H ;
Satoh-Nakagawa, T ;
Higuchi, M ;
Morikawa, Y ;
Miura, M ;
Kawakami, H ;
Seki, H ;
Takase, S ;
Sasaki, H .
NEUROSCIENCE LETTERS, 1998, 256 (03) :174-176
[7]
Pathological alterations of the climbing fibres of the cerebellum in vascular dementia: A Golgi and electron microscope study [J].
Baloyannis, Stavros J. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 257 (1-2) :56-61
[8]
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A [J].
Bell, Robert D. ;
Winkler, Ethan A. ;
Singh, Itender ;
Sagare, Abhay P. ;
Deane, Rashid ;
Wu, Zhenhua ;
Holtzman, David M. ;
Betsholtz, Christer ;
Armulik, Annika ;
Sallstrom, Jan ;
Berk, Bradford C. ;
Zlokovic, Berislav V. .
NATURE, 2012, 485 (7399) :512-516
[9]
Cerebrospinal fluid neurochemical phenotypes in vascular dementias: Original data and mini-review [J].
Bibl, Mirko ;
Mollenhauer, Brit ;
Esselmann, Hermann ;
Schneider, Michael ;
Lewczuk, Piotr ;
Welge, Volker ;
Gross, Martin ;
Falkai, Peter ;
Kornhuber, Johannes ;
Wiltfang, Jens .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 25 (03) :256-265
[10]
BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371